Analyses of expressions and prognostic values of Polo-like kinases in non-small cell lung cancer

被引：0
|
作者：
Yu Zeng
Nanhong Li
Wang Liu
Mingqing Zeng
Junfen Cheng
Jian Huang
机构：
[1] The Second Affiliated Hospital of Guangdong Medical University,Department of Respiration
[2] Affiliated Hospital,Pathological Diagnosis and Research Center
[3] Guangdong Medical University,Graduate School
[4] Guangdong Medical University,Department of Pathology
[5] Guangdong Medical University,First Clinical School of Medicine
[6] Guangdong Medical University,undefined
来源：
Journal of Cancer Research and Clinical Oncology | 2020年 / 146卷
关键词：
Lung cancer; Polo-like kinases; Prognosis; Oncomine; Kaplan–Meier plotter;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2447 / 2460
页数：13
相关论文
共 50 条
  • [21] Shared and separate functions of polo-like kinases and aurora kinases in cancer
    Susanne M. A. Lens
    Emile E. Voest
    René H. Medema
    Nature Reviews Cancer, 2010, 10 : 825 - 841
  • [22] Shared and separate functions of polo-like kinases and aurora kinases in cancer
    Lens, Susanne M. A.
    Voest, Emile E.
    Medema, Rene H.
    NATURE REVIEWS CANCER, 2010, 10 (12) : 825 - 841
  • [23] Regulation of cell cycle checkpoints by polo-like kinases
    Suqing Xie
    Bin Xie
    Marietta Y Lee
    Wei Dai
    Oncogene, 2005, 24 : 277 - 286
  • [24] Can the P53 status predict the outcome of Polo-like kinase 1 inhibition in non-small cell lung cancer cell lines?
    Van den Bossche, J.
    Wouters, A.
    Deben, C.
    Deschoolmeester, V.
    Specenier, P.
    Pauwels, P.
    Peeters, M.
    Lardon, F.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : 27 - 27
  • [25] Therapeutic targeting of polo-like kinase 1 using RNA-interfering nanoparticles (iNOPs) for the treatment of non-small cell lung cancer
    McCarroll, Joshua A.
    Dwarte, Tanya
    Baigude, Huricha
    Dang, Jason
    Yang, Lu
    Erlich, Rafael B.
    Kimpton, Kathleen
    Teo, Joann
    Sagnella, Sharon M.
    Akerfeldt, Mia C.
    Liu, Jie
    Phillips, Phoebe A.
    Rana, Tariq M.
    Kavallaris, Maria
    ONCOTARGET, 2015, 6 (14) : 12020 - 12034
  • [26] Towards Prognostic Profiling of Non-Small Cell Lung Cancer: New Perspectives on the Relevance of Polo-Like Kinase 1 Expression, the TP53 Mutation Status and Hypoxia
    Van den Bossche, Jolien
    Deben, Christophe
    Op de Beeck, Ken
    Deschoolmeester, Vanessa
    Hermans, Christophe
    De Pauw, Ines
    Jacobs, Julie
    Van Schil, Paul
    Vermorken, Jan Baptist
    Pauwels, Patrick
    Peeters, Marc
    Lardon, Filip
    Wouters, An
    JOURNAL OF CANCER, 2017, 8 (08): : 1441 - 1452
  • [27] Epithelial-Mesenchymal Transition Predicts Polo-Like Kinase 1 Inhibitor-Mediated Apoptosis in Non-Small Cell Lung Cancer
    Ferrarotto, Renata
    Goonatilake, Ruchitha
    Yoo, Suk Young
    Tong, Pan
    Giri, Uma
    Peng, Shaohua
    Minna, John
    Girard, Luc
    Wang, Yuehong
    Wang, Liguang
    Li, Lerong
    Diao, Lixia
    Peng, David H.
    Gibbons, Don L.
    Glisson, Bonnie S.
    Heymach, John V.
    Wang, Jing
    Byers, Lauren A.
    Johnson, Faye M.
    CLINICAL CANCER RESEARCH, 2016, 22 (07) : 1674 - 1686
  • [28] The prognostic values and immune characteristics of polo-like kinases (PLKs) family: A pan-cancer multi-omics analysis
    Shen, Chong
    Wang, Tong
    Li, Kai
    Fu, Chong
    Yang, Shaobo
    Zhang, Zhe
    Wu, Zhouliang
    Li, Zhi
    Li, Zhuolun
    Lin, Yuda
    Zhang, Yu
    Guo, Jian
    Fan, Zhenqian
    Hu, Hailong
    HELIYON, 2024, 10 (07)
  • [29] Prognostic roles of PCNA expressions in non-small cell lung cancer: a meta-analysis
    Fan, Jun
    Zhou, Xudong
    Huang, Jian
    Wang, Xin
    Che, Guowei
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9 (03): : 5655 - 5665
  • [30] PROGNOSTIC FACTORS IN NON-SMALL CELL LUNG CANCER
    O'Byrne, K.
    LUNG CANCER, 2009, 64 : S3 - S3
12345